MAP2K7 and breast carcinoma: To confirm HeyA8 results, MDA-MB-231 and MCF-7 breast cancer cell lines showed similar increase in CXCR4 surface expression after treatment with MEK inhibitor U0126 and 3D spheroids as compared to adherent (Fig. 4C).